成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook >> journal list >> International Journal of Impotence Research >>article
International Journal of Impotence Research

International Journal of Impotence Research

IF: 2.79
Download PDF

Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.

Published:1 June 1996 DOI: PMID: 8858389
M Boolell, M J Allen, S A Ballard, S Gepi-Attee, G J Muirhead, A M Naylor, I H Osterloh, C Gingell

Abstract

Sildenafil (Viagra, UK-92,480) is a novel oral agent under development for the treatment of penile erectile dysfunction. Erection is dependent on nitric oxide and its second messenger, cyclic guanosine monophosphate (cGMP). However, the relative importance of phosphodiesterase (PDE) isozymes is not clear. We have identified both cGMP- and cyclic adenosine monophosphate-specific phosphodiesterases (PDEs) in human corpora cavernosa in vitro. The main PDE activity in this tissue was due to PDE5, with PDE2 and 3 also identified. Sildenafil is a selective inhibitor of PDE5 with a mean IC50 of 0.0039 microM. In human volunteers, we have shown sildenafil to have suitable pharmacokinetic and pharmacodynamic properties (rapid absorption, relatively short half-life, no significant effect on heart rate and blood pressure) for an oral agent to be taken, as required, prior to sexual activity. Moreover, in a clinical study of 12 patients with erectile dysfunction without an established organic cause, we have shown sildenafil to enhance the erectile response (duration and rigidity of erection) to visual sexual stimulation, thus highlighting the important role of PDE5 in human penile erection. Sildenafil holds promise as a new effective oral treatment for penile erectile dysfunction.

Substances (5)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Sildenafil citrate 171599-83-0 C28H38N6O11S 743 suppliers $5.00-$1880.00
Milrinone 78415-72-2 C12H9N3O 490 suppliers $5.00-$1728.00
GUANOSINE 3':5'-CYCLIC MONOPHOSPHATE 7665-99-8 C10H12N5O7P 97 suppliers $50.00-$1680.00
PDE5 2 suppliers Inquiry
PDE2 phosphodiesterase - Inquiry

Similar articles

IF:6.9

Avanafil for the Treatment of Erectile Dysfunction: A Multicenter, Randomized, Double-Blind Study in Men With Diabetes Mellitus

Mayo Clinic proceedings Irwin Goldstein MD , LeRoy A. Jones MD ,etc Published: 1 September 2012
IF:0

Teneligliptin: DPP-4 inhibitor in the treatment of type II Diabetes Mellitus

International Journal of Phytopharmacy K. Danao, M. Shende,etc Published: 30 August 2017